0001104659-22-047859.txt : 20220420
0001104659-22-047859.hdr.sgml : 20220420
20220420163004
ACCESSION NUMBER: 0001104659-22-047859
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220419
FILED AS OF DATE: 20220420
DATE AS OF CHANGE: 20220420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Orlinger Klaus
CENTRAL INDEX KEY: 0001768432
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38869
FILM NUMBER: 22838439
MAIL ADDRESS:
STREET 1: C/O HOOKIPA PHARMA INC.
STREET 2: 430 EAST 29TH STREET, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HOOKIPA Pharma Inc.
CENTRAL INDEX KEY: 0001760542
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815395687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 0114318906360
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
4
1
tm2213143d7_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-04-19
0
0001760542
HOOKIPA Pharma Inc.
HOOK
0001768432
Orlinger Klaus
C/O HOOKIPA PHARMA INC.
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
NEW YORK
NY
10118
0
1
0
0
Chief Scientific Officer
Stock Option (Right to Buy)
1.66
2022-04-19
4
A
0
48350
0
A
2032-04-19
Common Stock
48350
48350
D
25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
/s/ Reinhard Kandera, as Attorney-in-Fact
2022-04-20